Pidilite Industries Ltd
Pidilite Industries Ltd
Commodities F&OPidilite Industries Limited is a leading manufacturer of adhesives and sealants, construction chemicals, craftsmen products, DIY products and polymer emulsions in India. Most of the products have been developed through strong in-house R&D. Our brand name Fevicol has become synonymous with adhesives to millions in India and is ranked amongst the most trusted brands in the country. Some of our other major brands are M-Seal, Fevikwik, Fevistik, Roff, Dr. Fixit, Fevicryl, Motomax, Hobby Ideas, Araldite. [1]
Pidilite Industries is a high-quality compounder with 23% average ROE over 10 years and near-zero debt, but at 65.1x PE and 14.84x PB, the stock prices in years of future growth. With 72% analyst buy ratings but limited margin of safety, investors should hold existing positions but wait for better entry points.
Key Fundamentals
LargecapSpecialty ChemicalsChemicalsTechnical Indicators
Key Insights
Strengths
2- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 61.8%
Weaknesses
2- Stock is trading at 14.8 times its book value
- Working capital days have increased from 51.2 days to 116 days
Growth Rate
AI Analysis — Bull vs Bear
Pidilite Industries is a high-quality compounder with 23% average ROE over 10 years and near-zero debt, but at 65.1x PE and 14.84x PB, the stock prices in years of future growth. With 72% analyst buy ratings but limited margin of safety, investors should hold existing positions but wait for better entry points.
- Consistent ROE of 23% over 10 years demonstrates exceptional capital efficiency and durable competitive advantage
- Company is almost debt free, providing financial resilience and flexibility for future investments without leverage risk
- Compounded profit growth of 25% over 3 years significantly outpaces sales growth of 7%, indicating strong margin expansion
- 72.22% of analysts (13 out of 18) rate the stock a Buy, reflecting broad institutional confidence
- Healthy dividend payout ratio of 61.8% signals shareholder-friendly capital allocation and earnings quality
- TTM sales growth of 11% shows recovery and acceleration from the 3-year CAGR of 7%
- 10-year stock CAGR of 16% demonstrates long-term wealth creation track record for patient investors
- TTM profit growth of 17% outpacing sales growth of 11% indicates operating leverage and pricing power
- PE ratio of 65.1x is extremely elevated, requiring sustained high growth to justify current valuation
- Price-to-book of 14.84x leaves no margin of safety and prices the stock for perfection
- Working capital days have deteriorated sharply from 51.2 days to 116 days, signaling potential cash conversion issues
- Stock CAGR of only 7% over 1 year and 6% over 3 years suggests returns have stalled at current valuations
- Dividend yield of just 0.63% offers negligible income support relative to the valuation premium paid
- 16.67% of analysts (3 out of 18) rate the stock a Sell, indicating meaningful disagreement on valuation
- Compounded sales growth of only 7% over 3 years is modest for a stock commanding 65x earnings
- 5-year stock CAGR of 8% significantly trails the 10-year CAGR of 16%, suggesting mean reversion in returns
This is AI-generated analysis, not financial advice. Do your own due diligence.
Quarterly Results
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,689 | 3,275 | 3,076 | 3,130 | 2,902 | 3,395 | 3,235 | 3,369 | 3,141 | 3,753 | 3,554 | 3,710 | 3,583 |
| Expenses | 2,232 | 2,569 | 2,398 | 2,388 | 2,327 | 2,583 | 2,467 | 2,571 | 2,509 | 2,812 | 2,704 | 2,816 | 2,753 |
| Operating Profit | 458 | 706 | 678 | 742 | 575 | 812 | 768 | 798 | 632 | 941 | 850 | 894 | 831 |
| OPM % | 17% | 22% | 22% | 24% | 20% | 24% | 24% | 24% | 20% | 25% | 24% | 24% | 23% |
| Other Income | 23 | 23 | 32 | 37 | -23 | 54 | 57 | 56 | 55 | 86 | 50 | 60 | 57 |
| Interest | 12 | 12 | 13 | 13 | 13 | 12 | 12 | 12 | 14 | 14 | 13 | 13 | 14 |
| Depreciation | 76 | 73 | 75 | 79 | 113 | 84 | 88 | 90 | 97 | 97 | 100 | 101 | 97 |
| PBT | 393 | 644 | 622 | 687 | 426 | 770 | 725 | 752 | 576 | 916 | 787 | 840 | 777 |
| Tax % | 27% | 26% | 26% | 26% | 29% | 26% | 25% | 26% | 26% | 26% | 26% | 26% | 25% |
| Net Profit | 286 | 474 | 459 | 511 | 304 | 571 | 540 | 557 | 428 | 678 | 585 | 624 | 584 |
| EPS in Rs | 2.78 | 4.6 | 4.43 | 5.02 | 2.96 | 5.57 | 5.26 | 5.43 | 4.15 | 6.61 | 5.69 | 6.07 | 5.69 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4,844 | 5,361 | 5,617 | 6,078 | 7,078 | 7,294 | 7,293 | 9,921 | 11,799 | 12,383 | 13,140 | 14,601 |
| Expenses | 4,073 | 4,188 | 4,355 | 4,737 | 5,707 | 5,718 | 5,606 | 8,065 | 9,813 | 9,675 | 10,130 | 11,084 |
| Operating Profit | 771 | 1,173 | 1,262 | 1,341 | 1,371 | 1,576 | 1,686 | 1,856 | 1,986 | 2,708 | 3,011 | 3,517 |
| OPM % | 16% | 22% | 22% | 22% | 19% | 22% | 23% | 19% | 17% | 22% | 23% | 24% |
| Other Income | 40 | 81 | 115 | 153 | 130 | 97 | 74 | 39 | 55 | 63 | 221 | 252 |
| Interest | 16 | 13 | 14 | 16 | 26 | 34 | 37 | 42 | 48 | 51 | 50 | 54 |
| Depreciation | 118 | 100 | 115 | 120 | 133 | 170 | 201 | 240 | 270 | 341 | 358 | 395 |
| PBT | 678 | 1,141 | 1,248 | 1,359 | 1,342 | 1,470 | 1,522 | 1,614 | 1,723 | 2,379 | 2,823 | 3,320 |
| Tax % | 25% | 29% | 31% | 29% | 31% | 24% | 26% | 25% | 25% | 27% | 26% | 26% |
| Net Profit | 514 | 807 | 863 | 966 | 928 | 1,122 | 1,126 | 1,207 | 1,289 | 1,747 | 2,096 | 2,471 |
| EPS in Rs | 5 | 7.83 | 8.39 | 9.48 | 9.1 | 10.99 | 11.13 | 11.88 | 12.52 | 17 | 20.41 | 24.06 |
| Div. Payout % | 29% | 26% | 28% | 32% | 36% | 32% | 38% | 42% | 44% | 47% | 49% | 89% |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 51 | 51 | 51 | 51 | 51 | 51 | 51 | 51 | 51 | 51 | 51 | 102 |
| Reserves | 2,219 | 2,587 | 3,420 | 3,523 | 4,097 | 4,405 | 5,542 | 6,353 | 7,161 | 8,356 | 9,704 | 10,730 |
| Borrowings | 58 | 80 | 98 | 125 | 113 | 288 | 331 | 416 | 391 | 382 | 454 | 417 |
| Other Liabilities | 986 | 996 | 1,202 | 1,500 | 1,643 | 1,779 | 2,890 | 2,675 | 2,902 | 3,286 | 3,775 | 4,184 |
| Total Liabilities | 3,315 | 3,714 | 4,770 | 5,199 | 5,904 | 6,523 | 8,814 | 9,494 | 10,505 | 12,076 | 13,984 | 15,433 |
| Fixed Assets | 978 | 1,137 | 1,275 | 1,342 | 1,448 | 1,807 | 4,418 | 4,703 | 4,914 | 5,451 | 5,705 | 5,774 |
| CWIP | 462 | 158 | 148 | 228 | 242 | 259 | 294 | 225 | 406 | 148 | 129 | 329 |
| Investments | 370 | 706 | 1,443 | 1,246 | 1,548 | 1,186 | 516 | 459 | 881 | 2,235 | 3,551 | 4,350 |
| Other Assets | 1,505 | 1,713 | 1,904 | 2,383 | 2,666 | 3,270 | 3,586 | 4,107 | 4,304 | 4,242 | 4,598 | 4,981 |
| Total Assets | 3,315 | 3,714 | 4,770 | 5,199 | 5,904 | 6,523 | 8,814 | 9,494 | 10,505 | 12,076 | 13,984 | 15,433 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 552 | 907 | 794 | 796 | 845 | 1,280 | 1,392 | 955 | 1,558 | 2,724 | 2,287 | 2,828 |
| Investing | -436 | -491 | -879 | 39 | -513 | 103 | -1,688 | -558 | -899 | -1,769 | -1,542 | -1,224 |
| Financing | -165 | -371 | 41 | -790 | -361 | -849 | -76 | -468 | -656 | -742 | -918 | -1,673 |
| Net Cash Flow | -49 | 45 | -45 | 46 | -29 | 533 | -372 | -71 | 2 | 212 | -173 | -68 |
| Free Cash Flow | 143 | 742 | 671 | 524 | 591 | 836 | 1,040 | 581 | 1,060 | 2,171 | 1,839 | 2,239 |
| CFO/OP | 94 | 104 | 92 | 91 | 91 | 106 | 105 | 76 | 99 | 124 | 100 | 105 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 44 | 48 | 50 | 56 | 54 | 54 | 66 | 53 | 47 | 49 | 50 | 55 |
| Inventory Days | 88 | 89 | 100 | 102 | 95 | 100 | 133 | 114 | 98 | 86 | 103 | 98 |
| Days Payable | 45 | 53 | 54 | 69 | 59 | 67 | 109 | 70 | 57 | 70 | 85 | 86 |
| Cash Conversion Cycle | 86 | 84 | 96 | 89 | 90 | 88 | 91 | 96 | 88 | 66 | 68 | 66 |
| Working Capital Days | 27 | 36 | 40 | 49 | 48 | 36 | 23 | 43 | 40 | 19 | 19 | 116 |
| ROCE % | 32% | 45% | 39% | 36% | 33% | 33% | 28% | 25% | 24% | 30% | 30% | 31% |
Documents
Frequently Asked Questions about Pidilite Industries Ltd
What does Pidilite Industries Ltd do?
Where is Pidilite Industries Ltd (PIDILITIND) listed?
Which sector does Pidilite Industries Ltd belong to?
What is the market capitalisation of Pidilite Industries Ltd?
What is the PE ratio of Pidilite Industries Ltd?
What is the 52-week high and low of Pidilite Industries Ltd?
Does Pidilite Industries Ltd pay dividends?
What is the Return on Equity (ROE) of Pidilite Industries Ltd?
How can I research Pidilite Industries Ltd on Tapetide?
Company Information
Pidilite Industries Limited is a leading manufacturer of adhesives and sealants, construction chemicals, craftsmen products, DIY products and polymer emulsions in India. Most of the products have been developed through strong in-house R&D. Our brand name Fevicol has become synonymous with adhesives to millions in India and is ranked amongst the most trusted brands in the country. Some of our other major brands are M-Seal, Fevikwik, Fevistik, Roff, Dr. Fixit, Fevicryl, Motomax, Hobby Ideas, Araldite. [1]